JP2004217634A5 - - Google Patents

Download PDF

Info

Publication number
JP2004217634A5
JP2004217634A5 JP2003423896A JP2003423896A JP2004217634A5 JP 2004217634 A5 JP2004217634 A5 JP 2004217634A5 JP 2003423896 A JP2003423896 A JP 2003423896A JP 2003423896 A JP2003423896 A JP 2003423896A JP 2004217634 A5 JP2004217634 A5 JP 2004217634A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
protein
partial peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003423896A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004217634A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003423896A priority Critical patent/JP2004217634A/ja
Priority claimed from JP2003423896A external-priority patent/JP2004217634A/ja
Publication of JP2004217634A publication Critical patent/JP2004217634A/ja
Publication of JP2004217634A5 publication Critical patent/JP2004217634A5/ja
Abandoned legal-status Critical Current

Links

JP2003423896A 2002-12-24 2003-12-22 がんの予防・治療剤 Abandoned JP2004217634A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003423896A JP2004217634A (ja) 2002-12-24 2003-12-22 がんの予防・治療剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002373144 2002-12-24
JP2003423896A JP2004217634A (ja) 2002-12-24 2003-12-22 がんの予防・治療剤

Publications (2)

Publication Number Publication Date
JP2004217634A JP2004217634A (ja) 2004-08-05
JP2004217634A5 true JP2004217634A5 (https=) 2007-02-01

Family

ID=32911037

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003423896A Abandoned JP2004217634A (ja) 2002-12-24 2003-12-22 がんの予防・治療剤

Country Status (1)

Country Link
JP (1) JP2004217634A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130212721A1 (en) * 2010-08-16 2013-08-15 Kyushu University, National University Corporation Reagent for tumor testing and pharmaceutical composition for tumor prevention
BR112013005806B1 (pt) * 2010-09-10 2022-05-10 Epizyme, Inc Métodos para detectar se um indivíduo é um candidato para o tratamento com ou responsivo a um inibidor de ezh2 e usos terapêuticos do dito inibidor de ezh2
CA3094020A1 (en) * 2018-04-11 2019-10-17 Ionis Pharmaceuticals, Inc. Modulators of ezh2 expression

Similar Documents

Publication Publication Date Title
JP7128246B2 (ja) 抗炎症活性を有するペプチド、及びそれを含む組成物
ES2306483T3 (es) Proteina inhibidora de la ruta de señalizacion de wnt.
Chang et al. Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2
JP2004536614A5 (https=)
JP2006149395A5 (https=)
JP2004511201A5 (https=)
Lange et al. New eukaryotic semaphorins with close homology to semaphorins of DNA viruses
JP2012501165A5 (https=)
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
JP2004217634A5 (https=)
WO1997044454A3 (en) Human phospholipase inhibitor
JP2005512558A5 (https=)
JP2020127419A5 (https=)
Park et al. Molecular cloning and expression analysis of the STAT1 gene from olive flounder, Paralichthys olivaceus
KR20170073585A (ko) Cd44의 단리된 폴리펩타이드 및 이의 사용
RU2727013C2 (ru) Циклические аналоги галанина и пути их применения
IL169367A0 (en) Defensin proteins
Ziman et al. Differential expression of four alternate Pax7 paired box transcripts is influenced by organ-and strain-specific factors in adult mice
JP2008522632A5 (https=)
Minakhin et al. Transcription regulation by bacteriophage T4 AsiA
KR20160086864A (ko) 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물
RU2006119452A (ru) Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
WO2008099928A1 (ja) 蛋白質分解酵素活性を調節する作用を有する胎盤蛋白質及びその関連遺伝子
Tanaka et al. Amino acid sequence of troponin-I from Akazara scallop striated adductor muscle